sprite-preloader
Anzeige
Mehr »
Donnerstag, 21.06.2018 Börsentäglich über 12.000 News von 586 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19:08Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
19:08GlaxoSmithKline limits Shingrix orders, halts TV commercials amid 'unprecedented' demand
18:08Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
17:08Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
17:08After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term
17:08French regulators cite contamination, other issues at factory of Indian API maker Dhanuka Labs
MiFrances's Novacap scoops up U.S. CDMO
MiCDMO Minakem's new Belgium HPAPI facility in final qualifications ahead of opening
MiCVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT
MiDrug shortages again on the rise after 5 years of improvements, FDA says
MiOpioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes
MiWhy is AbbVie's tax rate so low? Humira patents cached in Bermuda: Reuters
MiAbbVie put gaming gremlins to work mining people's 'fear of finding out' they're sick
MiLions Health: Mylan CEO talks big and small creative ideas that make a difference
MiPfizer's 'Living With Cancer' wowed Cannes attendees, if not the pharma jury
MiNews of Note-Vaccine exemption 'hot spots,' NIAID's RSV vaccine study and more
MiDoctors worry Shingrix side effects will put patients off their second dose
MiLions Health, Day 2: Fear factors, pharma humor and how can we win next year?
MiBig Pharma executives jump to China startups for higher pay and more say: report
DiUniversal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO
DiSanofi recruits veteran French auto executive to replace outgoing CFO Contamine
DiWhat's next for embattled Allergan? Depends on pipeline performance, analysts say
DiLions Health, Day 1: Shiny statuettes, heart-tugging creative and opinions galore
DiFDA gives Indian drugmaker Glenmark its first approval for generics produced at U.S. plant
DiAtara Biotherapeutics building $55M CAR-T gene therapy plant in Southern California